Journal
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
Volume 49, Issue 10, Pages 1011-1023Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.jaac.2010.06.015
Keywords
methylphenidate; atomoxetine; attention-deficit/hyperactivity disorder; norepinephrine; dopamine
Categories
Funding
- Shire Pharmaceuticals
Ask authors/readers for more resources
Objective: This study examined the effects of the attention-deficit/hyperactivity disorder treatments, methylphenidate (MPH) and atomoxetine (ATM), on prefrontal cortex (PFC) function in monkeys and explored the receptor mechanisms underlying enhancement of PFC function at the behavioral and cellular levels. Method: Monkeys performed a working memory task after administration of a wide range of MPH or ATM doses. The optimal doses were challenged with the alpha(2)-adrenoceptor antagonist, idazoxan, or the D-1 dopamine receptor antagonist, SCH23390 (SCH). In a parallel physiology study, neurons were recorded from the dorsolateral PFC of a monkey performing a working memory task. ATM, SCH, or the alpha(2) antagonist, yohimbine, were applied to the neurons by iontophoresis. Results: MPH and ATM generally produced inverted-U dose-response curves, with improvement occurring at moderate doses, but not at higher doses. The beneficial effects of these drugs were blocked by idazoxan or SCH. At the cellular level, ATM produced an inverted-U dose-response effect on memory-related firing, enhancing firing for preferred directions (increasing signals) and decreasing firing for the nonpreferred directions (decreasing noise). The increase in persistent firing for the preferred direction was blocked by yohimbine, whereas the suppression of firing for the nonpreferred directions was blocked by SCH. Conclusions: Optimal doses of MPH or ATM improved PFC cognitive function in monkeys. These enhancing effects appeared to involve indirect stimulation of alpha(2) adrenoceptors and D-1 dopamine receptors in the PFC. These receptor actions likely contribute to their therapeutic effects in the treatment of attention-deficit/hyperactivity disorder. J. Am. Acad. Child Adolesc. Psychiatry, 2010;49(10):1011-1023.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available